Advertisement

Strahlentherapie und Onkologie

, Volume 187, Issue 3, pp 202–205 | Cite as

Healing of Late Endoscopic Changes in the Rectum between 12 and 65 Months after External Beam Radiotherapy

  • Gregor Goldner
  • Richard Pötter
  • Alexander Kranz
  • Alexandra Bluhm
  • Wolfgang Dörr
Original Article

Abstract

Purpose:

To evaluate the time course of late rectal mucosal changes after prostate cancer radiotherapy (RT).

Patients and Methods:

A rectosigmoidoscopy was performed at 12, 24, and 65 months after RT in 20 patients. Rectal mucosal changes (telangiectasia, congested mucosa, ulceration, stricture, and necrosis) were scored and documented according to the Vienna Rectoscopy Score (VRS, score 0–3).

Results:

VRS of 0 and 3, were found in 20% of patients (n = 4) and 5% of patients (n = 1), respectively at all time points. A shift of the VRS from 2 to 1 was found with incidence rates of 60% at 12 months and 20% at 65 months, which is equivalent to an improvement rate of 67%. Laser coagulation was required in 3 patients (15%) with rectal bleeding due to telangiectasia grade ≥2.

Conclusion:

Late rectal mucosal changes are frequent after pelvic RT. Generally only the incidence rates corresponding to the initial diagnosis of the complications, independent of subsequent recovery, are reported. The results reported in the present study show that complications often improve over time. Hence, the usual reports of complication rates overestimate the proportion of patients presenting with side effects of certain grades.

Key Words

Prostate cancer Radiotherapy Rectum Endoscopy Telangiectasia 

Heilung von Schleimhautveränderungen im Rektum zwischen 12 und 65 Monaten nach externer Strahlentherapie

Zusammenfassung

Hintergrund:

Wie entwickeln sich Schleimhautveränderungen am Rektum nach Radiotherapie des Prostatakarzinoms im zeitlichen Verlauf?

Patienten und Material:

Bei 20 Patienten wurde 12, 24 und 65 Monate nach RT eine Rektosigmoidoskopie durchgeführt. Rektale Schleimhautveränderungen wurden bewertet und entsprechend dem Wiener Rektoskopie-Score (VRS, Score 0–3) graduiert.

Ergebnisse:

Ein VRS-Score 0 und -Score 3 wurde bei 20% (4 Patienten) und bei 5% (1 Patient) zu jedem Zeitpunkt nach RT erhoben. Eine Verlagerung von VRS-Score 2 zu -Score 1 mit einer Inzidenzrate von 60% nach 12 Monaten und 20% nach 65 Monaten wurde nachgewiesen, entsprechend einer Verbesserung bei 67% der Patienten (Tabelle 2). Bei 3 Patienten (15%) wurde eine Laser-Koagulation aufgrund rektaler Blutungen mit Teleangiektasien Grad ≥2 durchgeführt.

Schlussfolgerung:

Rektale Schleimhautveränderungen nach RT des Beckens treten häufig auf. In der Regel werden lediglich die Inzidenzraten entsprechend dem erstmaligen Auftreten dokumentiert, unabhängig davon ob eine Verbesserung der Veränderungen, wie in dieser Arbeit nachgewiesen, eintritt. Durch diese Art der Präsentation wird der Anteil an Patienten mit einem bestimmten Schweregrad von Nebenwirkungen oftmals überschätzt.

Schlüsselwörter

Prostatakarzinom Radiotherapie Rektum Endoskopie Teleangiektasien 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chi KD, Ehrenpreis ED, Jani AB. Accuracy and reliability of the endoscopic classification of chronic radiation-induced proctopathy using a novel grading method. J Clin Gastroenterol 2005;39:42–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Cho KH, Lee CK, Levitt SH. Proctitis after conventional external radiation therapy for prostate cancer: importance of minimizing posterior rectal dose. Radiology 1995;195:699–703.PubMedGoogle Scholar
  3. 3.
    Denton A, Forbes A, Andreyev J, et al. Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev 2002;(1):CD003455.Google Scholar
  4. 4.
    Donner CS. Pathophysiology and therapy of chronic radiation-induced injury to the colon. Dig Dis 1998;16:253–61.PubMedCrossRefGoogle Scholar
  5. 5.
    Dolezel M, Odrazka K, Vaculikova M, et al. Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy. Strahlenther Onkol 2010;186:197–202.PubMedCrossRefGoogle Scholar
  6. 6.
    Garg AK, Mai WY, McGary JE, et al. Radiation proctopathy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2006;66:1294–305.PubMedCrossRefGoogle Scholar
  7. 7.
    Gilinsky NH, Burns DG, Barbezat GO, et al. The natural history of radiation-induced proctosigmoiditis: an analysis of 88 patients. Q J Med 1983;52:40–53.PubMedGoogle Scholar
  8. 8.
    Goldner G, Bombosch V, Geinitz H, et al. Moderate risk adapted dose escalation with 3-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy: first report on 5 year morbidity and biochemical control from a prospective Austrian-German multicenter Phase II trial. Strahlenther Onkol 2009;185:94–100.PubMedCrossRefGoogle Scholar
  9. 9.
    Goldner G, Dimopoulos J, Kirisits Ch, et al. Moderate dose-escalation in 3-D conformal localized prostate cancer radiotherapy: single institutional experience in 398 patients comparing 66Gy vs. 70Gy vs. 74Gy. Strahlenther Onkol 2009;185:438–45.PubMedCrossRefGoogle Scholar
  10. 10.
    Goldner G, Tomicek B, Becker G, et al. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients. Int J Radiat Oncol Biol Phys 2007;67:78–83.PubMedCrossRefGoogle Scholar
  11. 11.
    Kertesz T, Herrmann MK, Zapf A, et al. Effect of a prostaglandin—given rectally for prevention of radiation-induced acute proctitis—on late rectal toxicity. Results of a phase III randomized, placebo-controlled, double-blind study. Strahlenther Onkol 2009;185:596–602.PubMedCrossRefGoogle Scholar
  12. 12.
    O’Brien PC, Hamilton CS, Denham JW, et al. Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004;58:75–80.PubMedCrossRefGoogle Scholar
  13. 13.
    Saclarides TJ, King DG, Franklin JL et al. Formalin installation for refractory radiation-induced hemorrhagic proctitis: Report of 16 patients. Dis Colon Rectum 1996;39:196–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Swaroop VS, Gostout CJ. Endoscopic treatment of chronic radiation proctopathy. J Clin Gastroenterol 1998;27:36–40.PubMedCrossRefGoogle Scholar
  15. 15.
    Taylor JG, DiSario JA, Buchi KN. Argon laser therapy for hemorrhagic radiation proctitis: long-term results. Gastrointest Endosc 1993;39:641–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Wachter S, Gerstner N, Goldner G, et al. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors. Radiother Oncol 2001;59:65–70.PubMedCrossRefGoogle Scholar
  17. 17.
    Wachter S, Gerstner N, Goldner G, et al. Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma. Radiother Oncol 2000;54:11–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Zinicola R, Rutter MD, Falasco G, et al. Haemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapy. Int J Colorectal Dis 2003;18:439–44.PubMedCrossRefGoogle Scholar

Copyright information

© Urban & Vogel, Muenchen 2011

Authors and Affiliations

  • Gregor Goldner
    • 1
    • 3
  • Richard Pötter
    • 1
  • Alexander Kranz
    • 1
  • Alexandra Bluhm
    • 1
  • Wolfgang Dörr
    • 1
    • 2
  1. 1.Department of Radiotherapy and RadiobiologyVienna General Hospital, University of Vienna Medical SchoolViennaAustria
  2. 2.Department of Radiotherapy and Radiation Oncology, Medical Faculty Carl Gustav CarusUniversity of Technology DresdenDresdenGermany
  3. 3.Klinik für StrahlentherapieMedizinische Universität WienVienna 1090Austria

Personalised recommendations